Will Progress on Protecting Young Kids From RSV Be Reversed?

(MedPage Today) — Infectious disease experts are dismayed that the monoclonal antibody against respiratory syncytial virus (RSV) for infants, widely considered a crucial advance in public health, has been downgraded on the childhood immunization…